Team

Dmitry Poteryaev, Ph.D.
Dmitry Poteryaev, Ph.D.
  Chief executive officer

Graduate of the Biological Faculty of Moscow State University. Received a PhD in biological sciences, completing his postgraduate studies at the V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences (IMB RAS). He worked in academic institutions in Finland, Germany and Switzerland for 14 years in the field of molecular and cell biology, genetics, neurobiology, cancer biology, and biotechnology. Since 2011 he has been working in biopharmaceutical companies in R&D senior positions. 10 years of experience in developing new and generic biopharmaceuticals.


Ramiz Salimov, D.Sc.
Ramiz Salimov, D.Sc.
  Director of preclinical studies

Graduate of the Biological Faculty of Moscow State University. Received a doctorate in biological sciences from the V.V. Zakusov Scientific Research Institute of Pharmacology. Many years of experience in the field of preclinical research, which he conducted in the scientific center of the Alco company (Finland), the Institute of Pharmacology of the University of Bari (Italy), the Indiana University (USA) and other institutions. Author of several patents and over 150 scientific papers.


Alexander Vassilevski, Ph.D.
Alexander Vassilevski, Ph.D.
  Founder and scientific advisor

Graduate of the Biological Faculty of Moscow State University. Received a PhD in chemistry at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IBCh RAS), where he is now head of the Laboratory of Molecular Instruments for Neurobiology. Author of several patents and over 60 scientific papers.